Home › Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial
 

Keywords :   


Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial

2014-05-31 23:43:29| Logistics - Topix.net

Partial responses in patients with each of TrkA, ROS1 and ALK alterations, and in patients with each of lung cancer, colorectal cancer and neuroblastoma an oncology precision medicine biotechnology company, announced today that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company's proprietary oral ... (more)

Tags: data trial phase clinical

Category:Transportation and Logistics

Latest from this category

All news
16.11Tropical Storm Sara Graphics
16.11Tropical Storm Sara Forecast Discussion Number 11
16.11Tropical Storm Sara Wind Speed Probabilities Number 11
16.11Summary for Tropical Storm Sara (AT4/AL192024)
16.11Tropical Storm Sara Public Advisory Number 11
16.11Tropical Storm Sara Forecast Advisory Number 11
16.11Atlantic Tropical Weather Outlook
16.11Eastern North Pacific Tropical Weather Outlook
Transportation and Logistics »
16.11HestraFallLine3
16.11GBA
16.11 SKY PAD 3.0 XL
16.1125th
16.112022taxDVD
16.11
16.11
16.11 e
More »